Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
2.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz ; 64(4): 403-411, 2021 Apr.
Article in German | MEDLINE | ID: covidwho-1196567

ABSTRACT

The collection of data on SARS-CoV­2 tests is central to the assessment of the infection rate in the context of the COVID-19 pandemic. At the Robert Koch Institute (RKI), data collected from various laboratory data recording systems are consolidated. First, this article aims to exemplify significant aspects regarding test procedures. Subsequently the different systems for recording laboratory tests are described and test numbers from the RKI test laboratory query and the laboratory-based SARS-CoV­2 surveillance as well as accounting data from the Association of Statutory Health Insurance Physicians for SARS-CoV­2 laboratory tests are shown.Early in the pandemic, the RKI test laboratory query and the laboratory-based SARS-CoV­2 surveillance became available and able to evaluate data on performed tests and test capacities. By recording the positive and negative test results, statements about the total number of tests and the proportion of positive test rates can be made. While the aggregate test numbers are largely representative nationwide, they are not always representative at the state and district level. The billing data of the Association of Statutory Health Insurance Physicians can complement the laboratory data afterwards. In addition, it can provide a retrospective assessment of the total number of SARS-CoV­2 numbers in Germany, because the services provided by statutory health insurers (around 85% of the population in Germany) are included. The various laboratory data recording systems complement one another and the evaluations flow into the recommended measures for the pandemic response.


Subject(s)
COVID-19 , Pandemics , COVID-19 Testing , Germany/epidemiology , Humans , Retrospective Studies , SARS-CoV-2
4.
Euro Surveill ; 25(22)2020 06.
Article in English | MEDLINE | ID: covidwho-525953

ABSTRACT

Residents in long-term care facilities (LTCF) are a vulnerable population group. Coronavirus disease (COVID-19)-related deaths in LTCF residents represent 30-60% of all COVID-19 deaths in many European countries. This situation demands that countries implement local and national testing, infection prevention and control, and monitoring programmes for COVID-19 in LTCF in order to identify clusters early, decrease the spread within and between facilities and reduce the size and severity of outbreaks.


Subject(s)
Coronavirus Infections/diagnosis , Coronavirus/isolation & purification , Disease Outbreaks , Long-Term Care , Nursing Homes , Pandemics/prevention & control , Pneumonia, Viral/diagnosis , Aged , Aged, 80 and over , Betacoronavirus , COVID-19 , Coronavirus Infections/mortality , Coronavirus Infections/transmission , Coronavirus Infections/virology , Europe/epidemiology , Female , Humans , Male , Pneumonia, Viral/mortality , Pneumonia, Viral/transmission , Pneumonia, Viral/virology , SARS-CoV-2 , Vulnerable Populations
SELECTION OF CITATIONS
SEARCH DETAIL